Advagene Biopharma Co. Ltd.
Clinical trials sponsored by Advagene Biopharma Co. Ltd., explained in plain language.
-
Nasal spray shows promise for Hard-to-Control asthma
Disease control CompletedThis study tested a nasal spray called AD17002 in 40 adults with moderate to severe eosinophilic asthma that was not well controlled. Participants used the spray twice a week for 6 weeks. The goal was to see if the spray could improve lung function and reduce the need for rescue …
Phase: PHASE1, PHASE2 • Sponsor: Advagene Biopharma Co. Ltd. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New nasal spray aims to ease dust mite allergy symptoms
Symptom relief CompletedThis early-stage study tested a nasal spray called AD17002 in 48 adults with dust mite allergies. The goal was to see if it is safe and can reduce symptoms like sneezing and stuffy nose. Participants received either the spray or a placebo, and researchers tracked side effects and…
Phase: PHASE1, PHASE2 • Sponsor: Advagene Biopharma Co. Ltd. • Aim: Symptom relief
Last updated May 17, 2026 03:54 UTC